NFKB1 and metabolic dysfunction-associated steatohepatitis: Among them, the transcription factor NF-κB, as a master regulator in inflammation (Baker et al., 2011; Michelotti et al., 2013), is activated in rodent models and in patients with NASH (Dela Pena et al., 2005).